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Abstract. Confocal Laser Endomicroscopy (CLE) is novel handheld fluores-
cence imaging technology that has shown promise for rapid intraoperative di-
agnosis of brain tumor tissue. Currently CLE is capable of image display only 
and lacks an automatic system to aid the surgeon in diagnostically analyzing the 
images. The goal of this project was to develop a computer-aided diagnostic 
approach for CLE imaging of human glioma with feature localization function. 
Despite the tremendous progress in object detection and image segmentation 
methods in recent years, most of such methods require large annotated datasets 
for training. However, manual annotation of thousands of histopathology imag-
es by physicians is costly and time consuming. To overcome this problem, we 
constructed a Weakly-Supervised Learning (WSL)-based model for feature lo-
calization that trains on image-level annotations, and then localizes incidences 
of a class-of-interest in the test image. We developed a novel convolutional 
neural network for diagnostic features localization from CLE images by em-
ploying a novel multiscale activation map that is laterally inhibited and collater-
ally integrated. To validate our method, we compared the model output to the 
manual annotation performed by four neurosurgeons on test images. The model 
achieved 88% mean accuracy and 86% mean intersection over union on inter-
mediate features and 87% mean accuracy and 88% mean intersection over un-
ion on restrictive fine features, while outperforming other state of the art meth-
ods tested. This system can improve accuracy and efficiency in characterization 
of CLE images of glioma tissue during surgery, and may augment intraopera-
tive decision-making regarding the tumor margin and improve brain tumor re-
section. 
Keywords: deep learning, convolutional neural networks, weakly-supervised 
localization, endomicroscopy, glioma, brain tumor diagnosis, digital pathology 
1 Introduction 
Rapid intraoperative interpretation of suspected brain tumor tissue is of paramount 
importance for planning the treatment and guiding the neurosurgeon towards the op-
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timal extent of tumor resection. Handheld, portable Confocal Laser Endomicroscopy 
(CLE) is being explored as a fluorescence imaging technique for its ability to image 
histopathological features of tissue at cellular resolution in real time during brain 
tumor surgery [1–4]. CLE systems can acquire up to 20 images per second, with areas 
in the tumor resection bed interrogated as an “optical biopsy”. Hundreds of images 
may be acquired showing thousands of cells, but the images may be affected with 
artifacts such as red blood cells (for CLE systems operating in the blue laser range) 
and motion distortion, making them complicated to analyze. Although images may be 
interpreted as largely artefactual, detailed inspection often reveals image areas that 
may be diagnostic. CLE images present a new fluorescent image environment for the 
pathologist. Augmenting CLE technology with a computer aided system that can 
rapidly highlight image regions that may reveal malignant or spreading tumor would 
have great impact on intraoperative diagnosis. This is relevant for tumors such as 
gliomas where discrimination of margin regions is key to achieve maximal safe resec-
tion, which has been correlated with increased patient survival duration [5, 6]. 
Recent studies have shown that off-the-shelf Convolutional Neural Networks 
(CNNs) can be used effectively for classifying CLE images based on their diagnostic 
value [7, 8] and tumor type [9]. However, feature localization models have not been 
previously applied to CLE images. Feature localization models based on fully super-
vised learning require large number of images for object-level annotation of the fea-
tures, which is expensive and time consuming. To overcome this limitation, we used a 
weakly-supervised localization (WSL) approach. A WSL approach allowed the model 
to learn and localize the class-specific features from image-level labels. 
  A few groups have recently applied WSL approaches to medical images, including 
placenta scans [10], whole-slide images of colorectal cancer [11], diabetic retinopathy 
[12], microscopic cellular images [13], and lung computed tomography scans [14]. 
Here, we present a novel model for detection of histological features of glioma on 
CLE images trained on a dataset of CLE images acquired during brain surgery for this 
invasive tumor. The architecture included end-to-end Multi-Layer Class Activation 
Map (MLCAM) with Lateral Inhibition (LI) and Collateral Integration (CI) of the 
glioma feature localizer neurons. The model was able to segment the CLE images 
semantically by disentangling class-specific discriminative features that can comple-
ment interpretation by the physicians. Performance of the model was assessed by 
comparing its output to CLE image segmentations performed by neurosurgeons and 
other deep learning models. Additionally, we validated the significance of the 
MLCAM, LI and CI architecture components on the overall performance of the mod-
el. The model localized known diagnostic CLE features and revealed new CLE fea-
tures that correlated with the final classification and were not previously recognized 
by the reviewers. 
Unlike previous models that require patch labeling [11] or an extra step for creat-
ing the activation maps during testing [15], our model is solely trained based on the 
whole image-level labels. Furthermore, we did not limit the network to localize fea-
tures that are already known phenotypes to the physicians [13, 14]. CLE images are 
relatively novel to the pathology tissue diagnosis workflow. Although the tissue archi-
tecture suggestive for a certain tumor type can be identified on CLE images [1–4], 
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detailed characteristic brain tumor patterns for CLE images are not yet well described.  
Therefore, we used a more general concept (glioma diagnostic vs. nondiagnostic) that 
includes a range of known histological diagnostic elements (i.e., large nucleus, mitotic 
figures, hypercellularity, etc.) and allows for discovery of previously unrecognized 
features that may correlate with final image classification. Further investigation of 
detected features may deepen the understanding of glioma histopathological pheno-
types in CLE images, consequently improving their theranostic implications. 
2 Methods 
We constructed a WSL-based model to generate glioma Diagnostic Feature Maps 
(DFM) from CLE images, which includes three main components (see Figure 1): 1) 
Customized CNN architecture with new design of CAM at different CNN layers. 2) 
Lateral inhibition (LI) mechanism that suppresses the activation of DFM at locations 
where its competitor, nondiagnostic feature map (NFM), also exhibit high activation. 
3) Collateral integration (CI) mechanism that amplifies activation of DFM at locations 
where its allies at other layers also have high activations.  
For an input image ܫ௠ supplied to the CNN, the class scores (𝑆D for diagnostic 
and 𝑆N for nondiagnostic) are defined from three layers via global pooling of discrim-
inative regions estimated in each activation map (DFM, NFM). The class scores 
achieved from each layer, are then passed to independent softmax layers. The three 
predictions (probability of ܫ௠ being diagnostic (D) and nondiagnostic (ND)) achieved 
from the softmax layers are streamed into three multinomial logistic loss layers and 
inject the weight update into the CNN during backpropagation. The total loss is calcu-
lated by summing the three loss values. 
2.1 New Design of Class Activation Map (CAM) 
To produce the CAM from each layer, a new convolutional layer is stacked to sum its 
weighted feature planes. Formally, the DFM and NFM at location ሺݔ, ݕሻ achieved 
from layer ݖ௝, are defined as: 
 𝐷𝐹ܯሺݔ, ݕ, ݖ௝ሻ = ∑ ݓ௞భ௭ೕ𝑓௟ሺݔ, ݕ, ݖ௝ሻ௟ , (1) 
 ܰ𝐹ܯሺݔ, ݕ, ݖ௝ሻ = ∑ ݓ௞బ௭ೕ𝑓௟ሺݔ, ݕ, ݖ௝ሻ௟ , (2) 
where 𝑓௟ሺݔ, ݕ, ݖ௝ሻ is the activation of lth feature plane of layer ݖ௝ at location ሺx, yሻ and  ݓ௞భ௭ೕ and ݓ௞బ௭ೕ are the weights to produce the DFM and NFM, respectively. By apply-
ing GAP and then softmax function on DFM and NFM, the classification scores for 
different classes are calculated at each layer. Therefore, the softmax input for diag-
nostic (𝑆D) and nondiagnostic (𝑆N) class at layer ݖ௝ can be formulated as: 
 𝑆D = 1𝑊𝑧ೕ×𝐻𝑧ೕ ∑ DFM ሺx, y, ݖ௝ሻ௫,௬ = 1𝑊𝑧ೕ×𝐻𝑧ೕ ∑ ∑ ݓ௞భ௭ೕ𝑓௟ሺݔ, ݕ, ݖ௝ሻ௟௫,௬ , (3) 
 𝑆N = 1𝑊𝑧ೕ×𝐻𝑧ೕ ∑ NFM ሺx, y, ݖ௝ሻ௫,௬ = 1𝑊𝑧ೕ×𝐻𝑧ೕ ∑ ∑ ݓ௞బ௭ೕ𝑓௟ሺݔ, ݕ, ݖ௝ሻ௟௫,௬ , (4) 
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where 𝑊 ௭ೕ and ܪ௭ೕ are the width and height of DFM and NFM at layer ݖ௝. With the 
novel design of MLCAM, DFM, and NFM are produced in every forward pass and 
are updated through backpropagation. Furthermore, producing DFM from deeper 
layers empowers the overall predictive power of the model (i.e. labeling the detected 
region as diagnostic or nondiagnostic), while DFM from shallower layers allows larg-
er spatial resolution and more precise detection of fine regions. 
 
Fig. 1. Network architecture with Lateral Inhibition (LI) and Collateral Integration (CI) compo-
nents for weakly supervised localization of glioma diagnostic features. Bottom image shows a 
CLE image along with the final diagnostic feature map generated by the model.  
2.2 Lateral Inhibition and Collateral Integration of Localizer Neurons 
During the computation of DFM and NFM, some locations might be activated in both 
feature maps, which indicates the model’s confusion about the diagnostic value of 
those regions. The activation of DFM is downregulated in these regions, using NFM 
activations. This mechanism is known as neuronal lateral inhibition in neurobiology 
[16]). Furthermore, we upregulate the activation of regions which had higher recur-
rence of activation by integrating DFMs achieved from different layers. To combine 
these two neural interactions, we compose the following equation to produce the Final 
DFM (FDFM): 
 𝐹𝐷𝐹ܯሺݔ, ݕሻ = ∑ [𝐷𝐹ܯ′ሺݔ, ݕ, ݖ௜ሻ −௭೔, ௭ೕሺ௜≠௝ሻ𝐷𝐹ܯ′ሺݔ, ݕ, ݖ௜ሻ. ܰ𝐹ܯ′ሺݔ, ݕ, ݖ௜ሻ].  [𝐷𝐹ܯ′ሺݔ, ݕ, ݖ௝ሻ −𝐷𝐹ܯ′ሺݔ, ݕ, ݖ௝ሻ. ܰ𝐹ܯ′ሺݔ, ݕ, ݖ௝ሻ],   (5) 
where 𝐷𝐹ܯ′ሺݔ, ݕ, ݖ௜ሻ and ܰ𝐹ܯ′ሺݔ, ݕ, ݖ௜ሻ are the value of normalized diagnostic and 
nodiagnostic feature maps achieved from layer ݖ௜, after up-sampling to the original 
input image size. As shown in Eq. (5), the downregulation for layer ݖ௜ is implemented 
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by subtracting the 𝐷𝐹ܯሺݔ, ݕ, ݖ௜ሻ. ܰ𝐹ܯሺݔ, ݕ, ݖ௜ሻ term, which represents the confusing 
regions at this layer, from 𝐷𝐹ܯሺݔ, ݕ, ݖ௜ሻ. Lastly, 𝐹𝐷𝐹ܯሺݔ, ݕሻ is also normalized. 
Figure 1 presents the developed network’s architecture. The three inception modules 
have the same architecture, each combines filters of size 1 × 1, 3 × 3, 5 × 5 in parallel, 
and concatenates the outputs from each filter into a single tensor [17]. 
3 Experimental Setup and Results 
To train our model on image-level annotations, first, a “classification dataset” was 
created. The CLE images were acquired with an Optiscan 5.1 CLE as described pre-
viously [1]. The classification dataset included 6,287 CLE images (3,126 diagnostic 
and 3,161 nondiagnostic) from 20 patients with glioma brain tumors. If the CLE im-
age depicted any distinguishable diagnostic features, it was labeled as diagnostic and 
otherwise as nondiagnostic. Table 1 shows the composition of the classification da-
taset and the number of images used in each stage. 
 
Table 1. Number of Diagnostic (D) 
and Nondiagnostic (ND) images used 
for training, validation (Val), and test 
stage is presented. 
 D ND All 
Train 1714 1729 3443 
Val 487 511 998 
Test 925 921 1846 
Total 3126 3161 6287 
 
 
 
 
 
Fig. 2. Network architectures used for the 
ablation study. Top network shows the devel-
oped architecture without the LI and CI com-
ponents. Bottom network shows the MLGAP 
architecture [14] which combines the three 
CAMs and then uses a GAP layer for classifi-
cation.
The classification dataset was divided on a patient level for model development and 
test (12 cases for training, 4 cases for validation and 4 cases isolated for testing). Sto-
chastic Gradient Descent (SGD) with an initial learning rate of 0.001 and momentum 
of 0.9 was used to optimize the model’s parameters. Learning rate decay policy was 
set to step function with a gamma of 0.9 and step size of 500 iterations. Image crop-
ping and rotation were not used for augmentation because these might harm the valid-
ity of images. Since the diagnostic features could be very small, not every crop of a 
diagnostic image would be diagnostic. Also, there is no guarantee that the acquired 
CLE images are rotation invariant (e.g. the surgeons’ preference for holding the CLE 
probe). Training batch size was set to 15 images and it took 22,000 iterations to 
achieve the model with the minimum loss on classification of validation images. All 
the experiments were performed in Caffe [18] deep learning framework, using a Ge-
Force GTX 980 Ti GPU (6 GB memory). 
 The classification accuracy of the model was 84% on the test set (sensitivity = 
83.8%, specificity = 84.1%). To validate the efficacy of the WSL model, we tested 
the following three hypotheses. First, the model can correctly segment the image 
regions which have features that are indicative of glioma, confirmed by physicians at 
different scales (i.e., medium-sized intermediate and small-sized restrictive scales) 
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and without much reliance on previous exposure (i.e., images from training, valida-
tion and test stages). Second, the new components utilized (MLCAM, LI, and CI) 
increase the performance of the model in detecting the features (especially restrictive 
features) compared to the other state of the art WSL methods that lack them and re-
moving any of these would affect the model performance negatively. Third, the de-
veloped method can detect novel features in CLE images that were not previously 
recognized by the physicians. The three hypotheses were tested empirically, using 
image semantic segmentation task with the following evaluation metrics: mean accu-
racy (mean_acc), mean intersection over union (mean_IU), and frequency-weighted 
intersection over union (fw_IU). 
A segmentation dataset including 310 CLE images was acquired from images an-
notated by four neurosurgeons. Each observer highlighted the diagnostic glioma fea-
tures of each CLE images, independently. We used majority voting to process the 
annotation variations from the neurosurgeons. For rigorous assessment of the first 
hypothesis, the segmentation dataset included diagnostic regions at different scales. 
(145 images were annotated for both Intermediate (Set2-I) and Restrictive (Set2-R) 
features). Also, to study the effect of previous exposure of CLE image to the model, 
we used images from all three stages: 30 images from training (Set1), 145 images 
form validation (Set2), and 135 images from test set (Set3 and Set4)). To appraise the 
second hypothesis, we sequentially altered components of the designed architecture 
and assessed the resulting performance of the model (“ablation study”). All models 
were trained and tested on the same data with the same parameters to avoid any bias. 
Finally, to test the third hypothesis, our dataset included 55 CLE images that were 
known to be from glioma tumors but were initially classified as nondiagnostic (Set4). 
The model generated the segmentation mask by creating the FDFM of the input image 
with one forward pass and then thresholding (threshold value of 0.03 for intermediate 
and 0.2 for restrictive features). 
Table 2 shows experimental results of segmentation performance by ten different 
models with respect to the annotators. Each model constructs a DFM to create a seg-
mentation map: M1, similar to [14]; M2 – DFM and NFM of CAM 1,2, and 3 are first 
laterally inhibited and then collaterally integrated; M3 – CAM 1,2, and 3 are collater-
ally integrated; M4, M5, M6 – by laterally inhibiting the DFM and NFM of CAM 1, 
2, and 3, respectively; M7, M8, M9 – by using the DFMs from CAM 1, 2, and 3 
without any further processing; M10, similar to [15]. The first hypothesis proved to be 
true, since our developed model, M2, produced high mean_acc, mean_IU, and fw_IU 
for all the intermediate features from diagnostic images (Set1, Set2-I, and Set3). 
Moreover, it could segment the images from Set3 without significant change in 
mean_acc, while producing better fw_IU and mean_IU values on images that were 
previously revealed to it (Set1). Results from Set2-I and Set2-R images showed that 
all models generated much lower mean_IU and fw_IU on restrictive features com-
pared to intermediate features, except for M1 and M2 models, both of which utilize 
shallower layers for enhancing the DFM's spatial resolution. In all experiments, M2 
made the best performance for three measures (except in mean_acc for Set2-R), sup-
porting the second hypothesis about the significance of the utilized components 
(MLCAM, LI, and CI). Specifically, M4-M6 models outperformed other ablated 
7 
models (M7-M9), highlighting the significant value of LI. The higher mean_IU value 
of M6 and M9 compared to M4,5 and M7,8, respectively, indicates that more abstract 
features were learned by inception 3 than by inception 1,2. In the first round of re-
view, clinicians labeled Set4 images as nondiagnostic, however, after features were 
highlighted by the developed model, the clinicians re-classified Set4 images as diag-
nostic. The highest performance in Set4 belonged to M2 (mean_acc = 88% and 
mean_IU = 89%). High mean_IU value achieved by the model and clinical feedback 
emphasize significance and novelty of the features. 
Table 2. Segmentation performance by different models. M2* is the developed model.  
 Set M1 M2* M3 M4 M5 M6 M7 M8 M9 M10 
m
ea
n
_
a
cc
 Set1 0.71 0.88 0.71 0.75 0.75 0.77 0.71 0.71 0.71 0.7 
Set2-I 0.76 0.85 0.74 0.76 0.76 0.77 0.74 0.74 0.74 0.74 
Set3 0.72 0.86 0.72 0.75 0.75 0.76 0.72 0.72 0.72 0.72 
Set2-R 0.78 0.87 0.79 0.88 0.88 0.85 0.78 0.79 0.81 0.78 
Set4 0.74 0.88 0.74 0.76 0.76 0.78 0.74 0.74 0.74 0.72 
m
ea
n
_
IU
 
Set1 0.65 0.9 0.61 0.69 0.69 0.72 0.61 0.61 0.61 0.63 
Set2-I 0.69 0.86 0.67 0.69 0.71 0.73 0.65 0.67 0.67 0.69 
Set3 0.57 0.82 0.56 0.59 0.61 0.63 0.56 0.56 0.56 0.59 
Set2-R 0.77 0.88 0.29 0.57 0.63 0.59 0.27 0.29 0.31 0.63 
Set4 0.48 0.89 0.48 0.52 0.55 0.57 0.48 0.48 0.48 0.5 
fw
_
IU
 
Set1 0.8 0.99 0.8 0.83 0.85 0.87 0.8 0.8 0.8 0.8 
Set2-I 0.88 0.98 0.86 0.88 0.9 0.92 0.86 0.86 0.86 0.86 
Set3 0.65 0.88 0.65 0.69 0.71 0.73 0.65 0.65 0.65 0.67 
Set2-R 0.9 0.97 0.18 0.5 0.61 0.58 0.14 0.16 0.2 0.67 
Set4 0.38 0.79 0.35 0.42 0.44 0.46 0.35 0.35 0.35 0.4 
 
4 Conclusions 
In this study, a WSL model was developed to localize the diagnostic features of 
gliomas in CLE images. It utilizes three fundamental components for creating the 
final glioma DFM: multi-scale DFM, LI for removing confusing regions, and CI to 
spatially infuse diagnostic areas from DFMs with different spatial resolutions. The 
model could detect the diagnostic regions with high agreement compared with annota-
tion by neurosurgeon, from both diagnostic and nondiagnostic images (i.e., images 
that were initially designated as lacking diagnostic features) in intermediate and re-
strictive features, while outperforming other methods. Such an approach should be 
tested on larger datasets. Initial testing demonstrated that WSL has the potential to 
identify not only relevant, but novel or unrecognized diagnostic features in CLE im-
ages that were not previously discriminated by human inspection, requiring further 
investigation. This approach can be augmented with active learning and patch cluster-
ing to create an atlas of glioma phenotypes in CLE images. Further detailed studies 
correlating regular histology and CLE images are necessary for better understanding 
of glioma histopathological features on CLE images. 
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